Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The chart below compares the cost of an annualized semaglutide dosage from Hims, versus competitors: The pivot to liraglutide will allow Hims & Hers to prolong its operations in the weight-loss ...

The Fund aims to provide a higher total return (the combination of capital growth and income), net of the Ongoing Charge Figure, than the average return of the iBoxx Sterling Corporates GBP Index over ...

NORTHBROOK, IL, USA I April 17, 2025 I Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a ...

The US FDA has issued a complete response letter (CRL) to Regeneron Pharmaceuticals for a supplemental new drug application to add extended dosing intervals—up to every 24 weeks—to the label for EYLEA ...

As the popularity of peptides continues to rise in 2025, fueled by the success of GLP-1 medications like Semaglutide and Tirzepatide ... ensuring proper dosing and pharmaceutical-grade quality.

A standard dose of semaglutide is 2.4mg, but we start patients on much lower doses (0.25mg) and gradually build up to this by increasing the dose each month. This is because starting at the full ...